BLEICHROEDER LP
BLEICHROEDER LP is a Seed, Series A, Series B, Series C+ and other fund in the US, global and non-us investing in AI, Healthcare, commodities, currencies, equities, fixed-income and other.
- Stages
- Seed, Series A, Series B, Series C+, other
- Sectors
- AI, Healthcare, commodities, currencies, equities, fixed-income, other
- Invests in
- US-wide, global, non-us
- Actively investing
- Yes
- Founded
- 2019
- Assets under management
- $2.8B
Check size not disclosed
Thesis
Bleichroeder LP, established in 2019, is an investment advisory firm operating as a hedge fund with a historical lineage dating back to the 19th century. The firm's investment objective is capital appreciation, achieved through a bottom-up, research-oriented value investing philosophy with a global scope. They actively purchase securities of companies believed to be attractive at advantageous prices and sell them when prices adequately reflect future events. Their investment universe is broad, encompassing stocks, bonds, notes, options, other securities and derivatives, commodities, and currencies. Bleichroeder LP is flexible regarding market capitalization, investing in both U.S. and non-U.S. companies of all sizes, and may also engage in illiquid securities, including restricted securities and private placements. As of December 31, 2025, the firm managed approximately $2.43 billion in discretionary regulatory assets, with a prior reported AUM of $2.8 billion in February 2020.
Common questions
Does BLEICHROEDER LP invest at the Seed stage?
Yes. BLEICHROEDER LP lists Seed, Series A, Series B, Series C+ and other among the stages it invests in.
Where does BLEICHROEDER LP invest?
BLEICHROEDER LP invests in the US, global and non-us.